Results 11 to 20 of about 82,871,848 (297)

Association of advanced glycation end products in Dupuytren disease [PDF]

Journal of Orthopaedic Surgery and Research, 2018
Background Advanced glycation end products are associated with aging, hyperglycemia, and oxidative stress. Accumulation of advanced glycation end products can cause various pathological conditions; however, the association of Dupuytren’s disease with ...
Fumiaki Takase, Yutaka Mifune, Atsuyuki Inui, Yasuhiro Ueda, Takeshi Kataoka, Takeshi Kokubu, Ryosuke Kuroda   +6 more
doaj   +2 more sources

Osseous wound repair under inhibition of the axis of advanced glycation end-products and the advanced glycation end-products receptor

Journal of the Formosan Medical Association, 2015
Blockade of advanced glycation end-products (AGE) is able to reduce diabetic complications and control periodontitis. This study aimed to determine whether the application of aminoguanidine (AG), an AGE inhibitor, or N-phenacylthiazolium bromide (PTB), an AGE breaker, facilitates the healing of an osseous wound in non-diabetic animals.2.6 mm diameter ...
Sheng-Chueh Tsai, Yi-Han Jheng, Chen-Ying Wang, Yi-Wen Chen, Yu-Fang Lin, Chih-Cheng Chen, Po-Chun Chang   +6 more
openaire   +4 more sources

Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review [PDF]

International Archives of Otorhinolaryngology, 2016
Introduction High mobility group box 1 is a versatile protein involved in gene transcription, extracellular signaling, and response to inflammation. Extracellularly, high mobility group box 1 binds to several receptors, notably the receptor for advanced ...
Austin Nguyen, Sheila Bhavsar, Erinn Riley, Gabriel Caponetti, Devendra Agrawal   +4 more
doaj   +2 more sources

Polymorphisms of the receptor for advanced glycation end products and glyoxalase I and long-term outcome in patients with breast cancer

Tumor Biology, 2017
Receptor for advanced glycation end products and glyoxalase I metabolizing advanced glycation end product precursors may play important role in the pathogenesis and progression of cancer.
Petra Tesarova, Tomas Zima, Ales A Kubena, Marta Kalousova   +3 more
doaj   +2 more sources

Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality

Clinical Interventions in Aging, 2014
Yanzi Cheng,1 Jiwen Zhong,1 Yang Xiang,1 Fan Zeng,1 Dehong Cai,2,† Ling Zhao11Department of Intensive Care Unit, Zhuhai People’s Hospital, Zhuhai, Guangdong, People’s Republic of China; 2Department of Endocrinology, Zhujiang Hospital ...
Cheng YZ, Zhong JW, Xiang Y, Zeng F, Cai DH, Zhao L   +5 more
doaj   +1 more source

The receptor for advanced glycation end-products: A complex signaling scenario for a promiscuous receptor

Cellular Signalling, 2013
Firstly described in 1992, the receptor for advanced glycation end-products has attracted increasing attention due to its diverse ligand repertoire and involvement in several pathophysiological processes associated with inflammation such as in diabetes, cancer, autoimmune diseases and neurodegenerative diseases. This receptor in addition to its binding
Rojas, Armando, Delgado-Lopez, Fernando, Gonzalez, Ileana, Perez-Castro, Ramon, Romero, Jacqueline, Rojas, Israel   +5 more
openaire   +5 more sources

Alpha cell receptor for advanced glycation end products associate with glucagon expression in type 1 diabetes. [PDF]

Sci Rep, 2023
Hypoglycemia in type 1 diabetes associates with changes in the pancreatic islet α cells, where the receptor for advanced glycation end products (RAGE) is highly expressed.
Leung SS, Lenchik N, Mathews C, Pugliese A, McCarthy DA, Le Bagge S, Ewing A, Harris M, Radford KJ, Borg DJ, Gerling I, Forbes JM.   +11 more
europepmc   +2 more sources

Do advanced glycation end products contribute to food allergy? [PDF]

, 2023
Sugars can bind non-enzymatically to proteins, nucleic acids or lipids and form compounds called Advanced Glycation End Products (AGEs). Although AGEs can form in vivo, factors in the Western diet such as high amounts of added sugars, processing methods ...
P. K. Smith, O. J. L. Lesslar, Lesslar, OJL, Smith, PK, R. Berni Canani, Smith, P K, Berni Canani, R, Lesslar, O J L, Canani, R Berni, O'Mahony, L, Venter, C, C. Venter, L. O’Mahony   +12 more
core   +1 more source

Advanced Glycation End Product Recognition by the Receptor for AGEs [PDF]

Structure, 2011
Nonenzymatic protein glycation results in the formation of advanced glycation end products (AGEs) that are implicated in the pathology of diabetes, chronic inflammation, Alzheimer's disease, and cancer. AGEs mediate their effects primarily through a receptor-dependent pathway in which AGEs bind to a specific cell surface associated receptor, the ...
Xue, Jing, Rai, Vivek, Singer, David, Chabierski, Stefan, Xie, Jingjing, Reverdatto, Sergey, Burz, David S., Schmidt, Ann Marie, Hoffmann, Ralf, Shekhtman, Alexander   +9 more
openaire   +2 more sources

Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia [PDF]

JAMA Network Open, 2021
Advanced glycation end products (AGEs) and their receptor (RAGE) are implicated in the pathophysiological processes of dementia and potentially underlie the association of diabetes with neurodegeneration. However, longitudinal studies examining this association are lacking.To determine whether markers of the AGE-RAGE system are associated with ...
Chen, Jinluan, Mooldijk, Sanne, Licher, Silvan, Waqas, Komal, Ikram, Kamran, Uitterlinden, André, Zillikens, M.C., Ikram, Arfan   +7 more
openaire   +2 more sources